Sclerotherapy for hydroceles.
R K Rencken, M S Bornman, S Reif, I Olivier
Index: J. Urol. 143(5) , 940-3, (1990)
Full Text: HTML
Abstract
Sclerotherapy with 3% sodium tetradecyl sulfate and 3.5% rolitetracycline on an outpatient basis was applied to 55 hydroceles. The over-all cure rate was 96% with an average followup of 13 months. Of the patients 64% were cured after only 1 sclerosant instillation. A post-sclerotherapy operation was necessary in 4% of the patients. Pain of a significant degree occurred after sclerotherapy in only 29% of the patients. Sclerotherapy appears to be an effective, economical and safe form of outpatient therapy for hydroceles.
Related Compounds
Related Articles:
2008-06-27
[J. Chromatogr. A. 1195(1-2) , 107-16, (2008)]
Trichloroacetic acid in Norway spruce/soil-system. II. Distribution and degradation in the plant.
2004-07-01
[Chemosphere 56(4) , 327-33, (2004)]
2001-07-01
[Amyloid 8 Suppl 1 , 20-7, (2001)]
Combined effects of high doses of rolitetracycline and testosterone on the liver of mice.
1986-04-01
[Arch. Int. Pharmacodyn. Ther. 280(2) , 324-8, (1986)]
1987-09-01
[Res. Vet. Sci. 43(2) , 173-6, (1987)]